Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation
1 clinical trials · Condition
◉ Watch Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation
| Record | Firm | Date |
|---|---|---|
| Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal (NCT03064035) | HealthPartners Institute | 2017-04-05 |
Track Urgent Reversal of Vitamin K Antagonist (VKA) Anticoagulation automatically
Every clearance here is in the API, with alerts when new ones post.